Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope Share
MASH Rec CARD (13)
CLICK HERE TO SHARE YOUR STORY!
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
Menu
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
  • Join PW

Rare Cancer

  1. Home>
  2. Rare Cancer>
  3. Page 3
Father Raises Smoldering Myeloma Awareness After Shocking Diagnosis
source: pixabay.com

Father Raises Smoldering Myeloma Awareness After Shocking Diagnosis

  • Post author:Jessica Lynn
  • Post published:September 20, 2022
  • Post category:Multiple Myeloma/Smoldering Myeloma

Seven years ago, Dennis Smith started having extreme back pain. Dennis, 48 at the time, was extremely active. He loved playing football, going to the gym, and riding his bike.…

Continue Reading Father Raises Smoldering Myeloma Awareness After Shocking Diagnosis
A Peritoneal Cancer Diagnosis Isn’t Slowing Down This Doctor
source: pixabay.com

A Peritoneal Cancer Diagnosis Isn’t Slowing Down This Doctor

  • Post author:James Moore
  • Post published:September 15, 2022
  • Post category:Peritoneal cancer

According to a story from Yahoo News UK, Dr. Paula Hunt had a CT scan earlier this year with alarming results. The scan appeared to show a large tumor in…

Continue Reading A Peritoneal Cancer Diagnosis Isn’t Slowing Down This Doctor
INBRX-109 Earns EU Orphan Drug Status for Chondrosarcoma
Source: Pixabay.com

INBRX-109 Earns EU Orphan Drug Status for Chondrosarcoma

  • Post author:Jessica Lynn
  • Post published:September 14, 2022
  • Post category:Chondrosarcoma

  Currently, there are an estimated 30 million people within the European Union (EU) who have a rare disease. The “Orphan Medicines” (or Orphan Drug) program was designed to facilitate…

Continue Reading INBRX-109 Earns EU Orphan Drug Status for Chondrosarcoma
Treating Myelofibrosis: What Are The Unmet Needs?
source: shutterstock.com

Treating Myelofibrosis: What Are The Unmet Needs?

  • Post author:James Moore
  • Post published:August 23, 2022
  • Post category:primary myelofibrosis

According to a story from Cancer Network, the treatment landscape for myelofibrosis, a cancer of the bone marrow, still has substantial unmet need. An important component of treatment are JAK…

Continue Reading Treating Myelofibrosis: What Are The Unmet Needs?
First Participant Dosed in ITI-3000 Study for Merkel Cell Carcinoma
source: unsplash.com

First Participant Dosed in ITI-3000 Study for Merkel Cell Carcinoma

  • Post author:Jessica Lynn
  • Post published:August 12, 2022
  • Post category:Merkel cell cancer

  Could a vaccine help treat cancer such as Merkel cell carcinoma (MCC)? Immunomic Therapeutics believes so. Its therapeutic plasmid DNA (pDNA) vaccine, ITI-3000, is designed for those with MCC,…

Continue Reading First Participant Dosed in ITI-3000 Study for Merkel Cell Carcinoma
DSP-5336 Granted Orphan Drug Designation for AML
source: pixabay.com

DSP-5336 Granted Orphan Drug Designation for AML

  • Post author:Jessica Lynn
  • Post published:August 11, 2022
  • Post category:Acute Myeloid Leukemia

Currently, clinical-stage oncology company Sumitomo Pharma Oncology, Inc. is working to develop DSP-5336 for patients with acute myeloid leukemia (AML). The company even began recruiting for a Phase 1/2 study…

Continue Reading DSP-5336 Granted Orphan Drug Designation for AML
Life with Oligodendroglioma: Jack’s Story
Source: Pixabay.com

Life with Oligodendroglioma: Jack’s Story

  • Post author:Jessica Lynn
  • Post published:August 10, 2022
  • Post category:Oligodendroglioma

For most of his life, Jack O’Donnell was as healthy as can be. Even as he headed towards Oklahoma State University, ready to study engineering graphics and design drafting, Jack…

Continue Reading Life with Oligodendroglioma: Jack’s Story
A Novel 3-Step Treatment Improves Pancreatic Cancer in Mice Models
moreharmony / Pixabay

A Novel 3-Step Treatment Improves Pancreatic Cancer in Mice Models

  • Post author:Jessica Lynn
  • Post published:August 4, 2022
  • Post category:Pancreatic Cancer

In recent years, there have been advances in the treatment of pancreatic cancer. This is crucial, as the prognosis for this cancer is often poor, and the cancer itself is…

Continue Reading A Novel 3-Step Treatment Improves Pancreatic Cancer in Mice Models
Carfilzomib Shows Promise for Japanese Patients with Multiple Myeloma
source: pixabay.com

Carfilzomib Shows Promise for Japanese Patients with Multiple Myeloma

  • Post author:Jessica Lynn
  • Post published:July 27, 2022
  • Post category:Multiple Myeloma

Following the approval of carfilzomib (Kyprolis) for relapsed or refractory (R/R) multiple myeloma (MM) in Japan around two years ago, researchers sought to understand the safety and efficacy of the…

Continue Reading Carfilzomib Shows Promise for Japanese Patients with Multiple Myeloma
Insurance Finally Approves Surgery for Father with Pseudomyxoma Peritonei
source: pixabay.com

Insurance Finally Approves Surgery for Father with Pseudomyxoma Peritonei

  • Post author:Jessica Lynn
  • Post published:July 22, 2022
  • Post category:Pseudomyxoma peritonei

  In 2020, Anthony Di Laura and Jackie Cucullo were over-the-moon. The married couple had just learned that Jackie was pregnant with their first child. Anthony and Jackie were thrilled…

Continue Reading Insurance Finally Approves Surgery for Father with Pseudomyxoma Peritonei
This Baby’s Black Eye Turned Out to Be Neuroblastoma
https://pixabay.com/en/baby-care-child-cute-hand-face-20339/

This Baby’s Black Eye Turned Out to Be Neuroblastoma

  • Post author:Jessica Lynn
  • Post published:July 21, 2022
  • Post category:Neuroblastoma

In September 2020, Amelia Bradford turned eight months old. Her family loved their fun, wiggly, and happy baby. But then Amelia’s mother Danielle noticed something concerning: a facial bruise around…

Continue Reading This Baby’s Black Eye Turned Out to Be Neuroblastoma
Paxalisib Earns Orphan Drug Designation for Atypical Teratoid Rhabdoid Tumors
source: pixabay.com

Paxalisib Earns Orphan Drug Designation for Atypical Teratoid Rhabdoid Tumors

  • Post author:Jessica Lynn
  • Post published:July 13, 2022
  • Post category:Atypical Teratoid Rhabdoid Tumor

Those living with rare diseases or conditions often face difficulty in finding treatment options - or even spurring researchers to make headway within their disease states. To combat this and…

Continue Reading Paxalisib Earns Orphan Drug Designation for Atypical Teratoid Rhabdoid Tumors
Evorpacept for AML Earns Orphan Drug Designation
source: pixabay.com

Evorpacept for AML Earns Orphan Drug Designation

  • Post author:Jessica Lynn
  • Post published:July 12, 2022
  • Post category:Acute Myeloid Leukemia

In the United States, the Orphan Drug Act was established to incentivize drug developers and other stakeholders to begin developing therapies for rare diseases. Orphan Drug designation is now granted…

Continue Reading Evorpacept for AML Earns Orphan Drug Designation
MB-106 for WM Granted Orphan Drug Designation
source: pixabay.com

MB-106 for WM Granted Orphan Drug Designation

  • Post author:Jessica Lynn
  • Post published:July 8, 2022
  • Post category:Waldenstrom Macroglobulinemia

  According to Cure Today, the U.S. FDA granted Orphan Drug designation to MB-106, a novel CAR-T cell therapy designed to treat Waldenström macroglobulinemia (WM). In the United States, Orphan…

Continue Reading MB-106 for WM Granted Orphan Drug Designation
Early Findings Show DS-6000 Benefits for Ovarian Cancer, RCC
mohamed_hassan / Pixabay

Early Findings Show DS-6000 Benefits for Ovarian Cancer, RCC

  • Post author:Jessica Lynn
  • Post published:July 4, 2022
  • Post category:Ovarian Cancer/Renal Cell Carcinoma

  The American Society of Clinical Oncology (ASCO) Annual Meeting (“ASCO 22”) took place this year from June 2nd through the 6th, 2022. During this Annual Meeting, stakeholders within the…

Continue Reading Early Findings Show DS-6000 Benefits for Ovarian Cancer, RCC
VBI-1901 for Glioblastoma Granted Orphan Drug Designation
Unsplash: https://unsplash.com/photos/58Z17lnVS4U

VBI-1901 for Glioblastoma Granted Orphan Drug Designation

  • Post author:Jessica Lynn
  • Post published:July 4, 2022
  • Post category:Glioblastoma

  Have you ever heard of Orphan Drug designation? In the United States, this designation is granted to drugs or biologics that intend to treat, prevent, or diagnose rare diseases…

Continue Reading VBI-1901 for Glioblastoma Granted Orphan Drug Designation
Can Immune Checkpoint Inhibitors Worsen Proteinuria in mRCC?
source: pixabay.com

Can Immune Checkpoint Inhibitors Worsen Proteinuria in mRCC?

  • Post author:Jessica Lynn
  • Post published:July 1, 2022
  • Post category:Proteinuria/Renal Cell Carcinoma

  Sometimes, doctors choose to treat a certain condition with a specific medicine or class of medicines. But what happens when that medicine causes unintended and potentially harmful reactions? For…

Continue Reading Can Immune Checkpoint Inhibitors Worsen Proteinuria in mRCC?
How Does Depth of Response Impact Survival in Renal Cell Carcinoma?
qimono / Pixabay

How Does Depth of Response Impact Survival in Renal Cell Carcinoma?

  • Post author:Kendall Mason
  • Post published:June 29, 2022
  • Post category:Renal Cell Carcinoma

When it comes to cancer treatment, it's important to understand what leads to improvements in survival; knowing these things helps to provide the best outcome for the patient. That's why…

Continue Reading How Does Depth of Response Impact Survival in Renal Cell Carcinoma?
QXL138AM for Multiple Myeloma Earns Orphan Drug Designation
source: shutterstock.com

QXL138AM for Multiple Myeloma Earns Orphan Drug Designation

  • Post author:Jessica Lynn
  • Post published:June 28, 2022
  • Post category:Multiple Myeloma

In the United States, Orphan Drug designation is granted to drugs or biologics intended to treat, diagnose, or prevent rare or life-threatening diseases or conditions. Rare conditions are those affecting…

Continue Reading QXL138AM for Multiple Myeloma Earns Orphan Drug Designation
Ilixadencel for GISTs Granted Orphan Drug Designation
https://unsplash.com/photos/tV-RX0beDp8

Ilixadencel for GISTs Granted Orphan Drug Designation

  • Post author:Jessica Lynn
  • Post published:June 21, 2022
  • Post category:Gastrointestinal Stromal Tumors

In the United States, the FDA grants Orphan Drug designation to drugs or biologics intended to treat, prevent, or diagnose rare diseases or conditions. Do you know what makes a…

Continue Reading Ilixadencel for GISTs Granted Orphan Drug Designation
Positive Initial Data Available on Tovorafenib for Glioma
source: pixabay.com

Positive Initial Data Available on Tovorafenib for Glioma

  • Post author:Jessica Lynn
  • Post published:June 17, 2022
  • Post category:Glioma

Currently, no approved treatment options exist for children with pediatric low-grade glioma, the most common brain tumor found in children. However, shares Day One Biopharmaceuticals ("Day One") in a news…

Continue Reading Positive Initial Data Available on Tovorafenib for Glioma
Will Malaysia Set up a Fund for Rare Disease Patients?
source: pixabay.com

Will Malaysia Set up a Fund for Rare Disease Patients?

  • Post author:Jessica Lynn
  • Post published:June 16, 2022
  • Post category:Rare Disease

In the United States, a rare disease or condition is one which affects fewer than 200,000 individuals. Alternately, a rare condition in the European Union (EU) is considered one which…

Continue Reading Will Malaysia Set up a Fund for Rare Disease Patients?
Do We Need a “Rule Book” to Speak With Terminally Ill Patients?

Do We Need a “Rule Book” to Speak With Terminally Ill Patients?

  • Post author:Rose Duesterwald
  • Post published:June 15, 2022
  • Post category:Cancer/Rare Disease

We have been told occasionally that certain phrases we use when speaking with a terminally ill patient may sound insensitive. We have also been told what we should not say…

Continue Reading Do We Need a “Rule Book” to Speak With Terminally Ill Patients?
A Novel Treatment for Pancreatic Cancer, a Deadly Disease

A Novel Treatment for Pancreatic Cancer, a Deadly Disease

  • Post author:Rose Duesterwald
  • Post published:June 15, 2022
  • Post category:Pancreatic Cancer

Pancreatic cancer is one of the deadliest forms of cancer. According to the American Cancer Society (ACS), only about 11% of patients are expected to survive more than five years…

Continue Reading A Novel Treatment for Pancreatic Cancer, a Deadly Disease
A Car Crash Saved the Life of a Woman with a Thymoma
https://pixabay.com/en/cuba-oldtimer-old-car-forest-red-1197800/

A Car Crash Saved the Life of a Woman with a Thymoma

  • Post author:Jessica Lynn
  • Post published:June 13, 2022
  • Post category:Rare Disease/Thymic epithelial tumor

It is very rare that one might say that a car accident saved their life – but Yolanda Carusciello, who lives in Brooklyn, can say just that. Of course, when…

Continue Reading A Car Crash Saved the Life of a Woman with a Thymoma
  • Go to the previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 13
  • Go to the next page
You Are Not Alone: Empowering the Advanced Kidney Cancer Community
Finding Light Through Story-The Power of Ambassadorship in the Endometrial Cancer Community
*cancer that cannot be removed with surgery or has spread to other parts of the body. GEJ= gastroesophageal junction (where the esophagus joins the stomach)
Read Full Story Here
CLICK HERE TO SHARE YOUR STORY!
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Notice
Privacy Policy for CA Residents
EU/UK Privacy Notice
Data Privacy Framework: Consumer Privacy Policy
Consumer Health Data Privacy Policy
Cookie Notice

Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope

© Copyright 2024 Patient Worthy

Sign Up With a Patient Worthy Account and Share Your Rare Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info

We're Happy You're Here!

What best describes you when it comes to rare disease? (check all that apply)

What rare disease(s)/conditions are most important to you?

Visit Home Page or

Thank you for signing up for a Patient Worthy Account!

Have a rare disease story to share? Let us know

Share Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info